CNS Pharmaceuticals selects Worldwide Clinical Trials as contract research organization partner for Phase 2 Berubicin trials. HOUSTON, TX - CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biophar...

Read More

Contract research organization recognized as a top outsourcing partner for seventh consecutive year by Life Science Leader and Industry Standard Research Morrisville, NC, USA – Worldwide Clinical Trials, Inc., (World...

Read More

Morrisville, NC, USA – Worldwide Clinical Trials, Inc., (Worldwide) an award-winning, full-service, midsize, global contract research organization (CRO), announced today that Mike Mencer has joined the company as the...

Read More

Worldwide invests in delivery and growth in Latin America with new leader to aid in global expansion Morrisville, NC, USA – Worldwide Clinical Trials, Inc., (Worldwide) an award-winning, full-service, midsize, global...

Read More

Pivotal trial will study the intravenous administration of the Company’s Trappsol® Cyclo™ drug and will focus on systemic and neurologic outcomes Gainesville, FL, USA – Cyclo Therapeutics, Inc. (OTCQB: CTDH)...

Read More

Trial Will Evaluate Safety and Efficacy of the Company’s Trappsol® Cyclo™ Drug in Alzheimer’s Disease Gainesville, FL, USA – Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company t...

Read More